In Silico Screening of Available Drugs Targeting Non-Small Cell Lung Cancer Targets: A Drug Repurposing Approach

The RAS–RAF–MEK–ERK pathway plays a key role in malevolent cell progression in many tumors. The high structural complexity in the upstream kinases limits the treatment progress. Thus, MEK inhibition is a promising strategy since it is easy to inhibit and is a gatekeeper for the many malignant effect...

Descripción completa

Detalles Bibliográficos

Autores principales:	Muthu Kumar Thirunavukkarasu, Utid Suriya, Thanyada Rungrotmongkol, Ramanathan Karuppasamy
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2021-12-01
Colección:	Pharmaceutics
Materias:	drug-repositioning MEK inhibitor MM/GBSA Glide docking MD simulation MM/PBSA
Acceso en línea:	https://www.mdpi.com/1999-4923/14/1/59
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!